Towle & Co’s Cross Country Healthcare CCRN Stock Holding History

Towle & Co’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-36,100	Closed	-$806K	–	58
2023 Q1	$806K	Sell	36,100 -4,480	-11%	-$117K	0.11%	48
2022 Q4	$1.08M	Buy	40,580 +12,560	+45%	+$410K	0.14%	41
2022 Q3	$795K	Buy	+28,020	New	+$720K	0.13%	34

Other funds holding CCRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

SCM

Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Towle & Co's CCRN Position: Q2 2023 in Review

Towle & Co sold out of Cross Country Healthcare (CCRN) in Q2 2023, closing a stake of 36,100 shares — an estimated $806K sold.

Towle & Co first reported a position in CCRN in Q3 2022 and held it in 3 quarters. The position peaked at $1.08M in Q4 2022. 194 funds tracked by Wall St. Rank hold CCRN as of Q2 2023.

Towle & Co reported no remaining Cross Country Healthcare position as of Q2 2023 after selling out during the quarter.
Towle & Co sold 36,100 Cross Country Healthcare shares in Q2 2023, an estimated $806K.
Towle & Co first reported a position in Cross Country Healthcare in Q3 2022 and held it in 3 quarters.
Towle & Co's Cross Country Healthcare position peaked at $1.08M in Q4 2022.
194 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2023.

Based on Towle & Co's 13F filing for Q2 2023, filed 14 Aug 2023.